Participants Needed for Study on Dilated Cardiomyopathy (DCM) in Dogs
Hill's Pet Nutrition and Embark have partnered on a study that looks to test 1,000+ in an effort to learn more about treating and preventing DCM in dogs.
Hill’s Pet Nutrition and Embark are partnering on a research project to learn more about dilated cardiomyopathy (DCM) in dogs. The companies are asking pet owners to fill out a survey for possible inclusion in the study, which aims to genetically test more than 1,000 dogs diagnosed with DCM.
DCM, a potentially fatal adult-onset disease of the heart muscle, can be better treated with an early diagnosis. Hill’s and Embark say the goal of the study is to “explore options for early detection of DCM, genetic risk factors for DCM (nutritional and non-nutritional), and potential solutions to support healthy recovery of affected dogs.”
While previous DCM studies have focused on large, pure breed dogs, this research will include mixed breed dogs that have been diagnosed with DCM as well. The cost of the DNA kit will be covered for approved participants. Interested pet owners who have clinical documentation of a diagnosis, including an echocardiogram, can fill out the survey to participate here.
“Hill’s and Embark share a relentless commitment to pet wellbeing,” said Dave Baloga, Vice President of Science and Technology for Hill’s Pet Nutrition in a press release. “We have the scientific programs and capabilities necessary to undertake a data-driven study of this scope and depth to bring our understanding of the underlying factors of this disease to a new level, which could lead to early diagnostics and potential for improved nutritional interventions.”
For additional information, veterinary professionals and pet owners can contact [email protected]